PATENT CLAIM ANALYSIS

Application Number: 15879792
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "338000"]

Abstract:
Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.

Claim (Index 23):
A composition comprising a compound of  claim 22 , wherein the composition is pharmaceutically acceptable and further comprises a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14853815', '15339590', '15591884', '14776271', '15846198']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7678117896835589
- 35 USC 102 Novelty (BERT): 0.5308637516558308
- Combined Prediction Score: 0.7441169858807861
- Mean Citation Score: 322.760368
- Max Citation Score: 354.08676
- Similarity Product: 229.3650032904553

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test